Trial master file documents for TMF classification and QC AI

This guide sits in the industry-specific operational data hub and narrows the general advice in document classification training data to the TMF taxonomy. It covers how to specify labels, how to value QC findings, which privacy issues travel with the documents, and how to evaluate a supplier sample.

Why TMF classification needs real, vault-shaped documents

Real TMF documents beat synthetic or public corpora because the hard cases come from scan quality, multi-document PDFs, site-specific templates and near-duplicate artifact types that generators do not reproduce. Production eTMF models already train on this kind of data. Veeva's help documentation for Vault Clinical TMF Bot says the model is trained on the vault's own steady-state documents, rebuilt nightly, and applied with a default prediction confidence threshold of 0.95, with training data kept inside the vault [1]. That design keeps each customer's model local, but it leaves vendors and CROs short of cross-sponsor data for cold-start models, new-customer onboarding and benchmarking.

Public document benchmarks will not close that gap. Work on document image classifiers shows that models trained on standard benchmarks lose accuracy on out-of-distribution documents [6]. A TMF classifier that never saw a faxed IRB approval letter, a wet-ink-signed 1572 or a CRO-branded monitoring visit report template will fail on exactly those documents. For the broader trade-off, see synthetic versus real documents.

Labeling against a pinned TMF Reference Model version

Every label set should name the exact TMF Reference Model version it was mapped to, because artifact numbers and definitions change between releases. The model, now maintained under CDISC [11], organizes the TMF into zones, sections and artifacts, and later releases added sub-artifacts. As of October 2026, confirm the current release with the supplier and ask whether any part of the corpus was originally filed under v2.x or v3.0 and later remapped.

Three structural facts shape the label design:

• Artifacts are buckets, not document types. Many artifacts (for example "Monitoring Visit Report" or "Relevant Communications") hold several sponsor-specific sub-artifacts. Ask for both the reference-model artifact and the supplier's local sub-artifact name, plus the mapping table.
• Level matters. The same artifact can be filed at trial, country or site level. A CV filed at trial level instead of site level is a misfile even if the artifact is right, so the label is the pair (artifact, level) plus country and site keys.
• Remaps leave scars. Sponsors that migrated eTMF systems or reference-model versions often carry legacy artifact codes. A corpus where 10% of labels come from an automated remap is noisier than its QC pass rate suggests.

ProPharma's guidance for TMF Bot deployments gives a useful floor: 1,000 to 3,000 accurately classified steady-state documents, at least 10 per document type, and excluding non-English, media and database files [2]. Treat those as the minimum for a single-vault model, not a target for a cross-sponsor training set. For rare artifacts (financial disclosure forms, IP release records, unblinding documentation) you will need oversampling or explicit few-shot evaluation splits.

How ICH E6(R3) changes the document mix

ICH E6(R3) replaced "essential documents" language with essential records, so corpora built under E6(R2) checklists may underrepresent electronic and system-generated records. The guideline reached ICH Step 4 in early 2025 [12] and treats essential records in a dedicated appendix. Adoption by individual regulators follows national or regional procedures, so verify effective dates for the regions your customers operate in.

For a training buyer, the practical consequence is document-mix drift. Trials run under R3-aligned SOPs will file more system audit-trail exports, decentralized-trial vendor records and risk-proportionate monitoring outputs (central monitoring reports, key risk indicator summaries). Ask suppliers to tag each study with the GCP revision and SOP version it ran under, and split evaluation by that tag. Protocols and amendments themselves are a separate corpus; see clinical trial protocols and amendment histories.

QC findings are labels, not just cleanup

QC history is the most valuable layer in a TMF corpus because each finding records a disagreement between filer and reviewer. Phlexglobal frames TMF AI performance as dependent on large volumes of quality-checked, correctly classified documents [3], and TransPerfect describes human-aided active learning where reviewers confirm or correct predictions [4]. Both approaches generate finding records that most corpora discard.

Request QC findings as structured rows, not free-text notes. Useful finding categories include wrong artifact, wrong level, wrong site or country, wrong document date, missing signature or date, illegible scan, duplicate, wrong version, and missing required metadata. These categories map directly to model heads: classification, metadata extraction, completeness and signature presence. For the signature head, compare with signature and stamp detection data.

Use the findings to estimate label noise before training. Confident learning estimates class-conditional noise and ranks likely mislabeled examples [5]; run it on the supplier's final labels and compare the flagged pairs against the QC finding rate for those artifacts. If the method flags artifact pairs that QC never touched, the QC sample probably skipped them.

Privacy: investigators, site staff and subject IDs

TMF documents carry personal data even when they contain no patient names. Investigator CVs, medical licenses, GCP training certificates, 1572s and delegation logs name and describe site staff. Monitoring visit reports and deviation logs reference subject IDs, visit dates and sometimes adverse event descriptions.

Subject IDs are pseudonymous, not anonymous. Under GDPR Recital 26, data that can be attributed to a person using additional information, such as the site's subject identification log, remains personal data [7]. EU sites therefore bring GDPR into scope for the corpus, and EDPB Opinion 28/2024 is the reference for whether a model trained on such data can itself be considered anonymous [8]. De-identification reduces risk without removing it; NIST's survey documents re-identification of data released as de-identified [9].

Ask suppliers how they treated each field class: staff names and signatures (masked, replaced or retained with consent), subject IDs (re-keyed consistently across documents so cross-document linking survives), dates (shifted per study), and free-text clinical narrative in monitoring reports. Where site source documents or patient-level medical records slipped into the TMF, ask how HIPAA de-identification was applied. For scanned pages, redaction must cover the pixel layer, the OCR text layer and PDF metadata; see redacting PII in scanned documents.

This page is general information, not legal advice. Confirm requirements with counsel for your jurisdiction and use case.

Record schema and request checklist

A usable TMF training record links the file, its final label, its filing context and its QC trail. The schema below shows the minimum fields worth requesting.

Illustrative example: invented to show structure; it does not describe an available dataset.

{
  "doc_id": "d-000481",
  "study_key": "STUDY-A",
  "trial_phase": "2",
  "gcp_revision": "E6(R2)",
  "tmf_rm_version": "3.3.0",
  "artifact_code": "05.04.03",
  "artifact_name": "Monitoring Visit Report",
  "local_subartifact": "Interim Monitoring Visit Report",
  "filing_level": "site",
  "country": "DE",
  "site_key": "S-017",
  "document_date": "2024-03-12",
  "language": "en",
  "page_count": 14,
  "source_format": "scanned_pdf",
  "ocr_layer": true,
  "label_source": "qc_confirmed",
  "qc_events": [
    {"stage": "first_qc", "finding": "wrong_level", "from": "country", "to": "site"},
    {"stage": "first_qc", "finding": "document_date_mismatch"}
  ],
  "deid": {"staff_names": "replaced", "subject_ids": "rekeyed", "dates": "shifted_per_study"}
}

The artifact code above is a placeholder; map codes from the reference model release you pin. Before signing, run this checklist against the supplier's sample:

Hold out entire studies and sponsors, not random documents, for evaluation. Random splits leak site templates and staff names across train and test and inflate accuracy. For metadata fields such as document date and site, build field-level ground truth as described in document extraction evaluation sets.

How SourceX handles TMF document requests

SourceX sources operational datasets from US companies on request; it holds no stock, and a request does not guarantee a match. Buyers describe the documents, labels and QC history they need, and SourceX looks for US businesses that hold that data. Every release is approved by the supplying company.

Each dataset is rights-reviewed for ownership and consents, personal details are removed or replaced before delivery with the method recorded and a sample checked, and delivery happens under a license that defines records, uses, term and delivery. The process runs Find, Assess, Agree, Transact and Manage, and nothing is contracted until a supplier agrees. Life sciences buyers can start from the healthcare buyers page or describe the request on the SourceX buyer intake.

Related reading: training data for document understanding models, enterprise document datasets, and clinical study reports for medical writing AI.

Request labeled TMF document data

Describe the artifact coverage, reference model version, QC history and de-identification you need, and SourceX will look for US companies that hold matching records. Every dataset is rights-reviewed and delivered under a license that defines records, uses, term and delivery. Start a TMF data request on the buyers page.